Novavax Announces COVID-19 Vaccine Clinical Development Progress

Go back to Novavax Announces COVID-19 Vaccine Clinical Development Progress
Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.79 --0 (-0%)
Previous Close $8.79    52 Week High $9.23 
Open $8.79    52 Week Low $1.16 
Day High $8.79    P/E N/A 
Day Low $8.79    EPS $-0.30 
Volume 162,901       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.79 --0 (-0%)
Previous Close $8.79    52 Week High $9.23 
Open $8.79    52 Week Low $1.16 
Day High $8.79    P/E N/A 
Day Low $8.79    EPS $-0.30 
Volume 162,901